Hepatitis related to amoxicillin or levofloxacin: A case report [3];À propos d'un cas d'hépatite aiguië mé dicamenteuse mixte après traitement par amoxicilline et lévofloxacine

Revue de Medecine Interne

Volumn 24, Issue 12, 2003, Pages 841-843

  Heluwaert, F ^a,c   Roblin, X ^b   Duffournet, V ^a   Capony, P ^a   Martin, D ^a  

^a Centre Hospitalier de la Region d'Annecy   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c NONE   (France)

Author keywords

Amoxicillin; Drug induced hepatitis; Levofloxacin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMOXICILLIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; LEVOFLOXACIN; URSODEOXYCHOLIC ACID; ANTIINFECTIVE AGENT; OFLOXACIN;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC THERAPY; CASE REPORT; CHOLESTASIS; DISEASE ASSOCIATION; DRUG SURVEILLANCE PROGRAM; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; LETTER; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TOXICITY; SINUSITIS; SKIN MANIFESTATION; VOMITING; PATHOLOGY; TOXIC HEPATITIS;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; FEMALE; HEPATITIS, TOXIC; HUMANS; OFLOXACIN;

EID: 0347625652     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2003.07.001     Document Type: Letter

References (17)

1. Mallat A. Hépatites médicamenteuses: diagnostic et prise en charge. Gastroenterol Clin Biol 1999;23:906-14.
2. Garcia Rodriguez LA, Stricker BH, Zimmerman HJ. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 1996;156:1327-3224.
3. Davies MH, Harrison RF, Elias E, Hübscher SG, Antibiotic-associated acute vanishing bile duct syndrome. J Hepatol 1994;20:112-6.
4. Bolzan H, Spatola J, Castelleto R, Curciarello J. Intrahepatic cholestasis induced by amoxicillin alone. Gastroenterol Hepatol 2000;23(5):237-9.
5. Chapoutot C, Larrey D. Les hépatites et les atteintes des voies biliaires dues it l'amoxicilline acide clavulanique. Hépato-Gastro 1998;5:45-52.
6. O'Donohue J, Oien KA, Donaldson P, Underhill J, Clare M, MacSwoon RN, Mills PR. Co-annoxiclav jaundice: clinical and histological features and HLA class II association. Gut 2000;47:717-20.
7. Lopez-Natividad A, Domingo P, Cadafalch J, Farrerons J. Norfloxacin-induced hepatotoxicity. J Hepatol 1990;11:277-8.
8. Jones SE, Smith RH. Quinolones may induce hepatitis. Br Med J 1997;314:869.
9. Hautekeete ML, Kockx MM, Naegels S, Holvoet JK, Hubens H, Klöppel G. Cholestatic hepatitis related to quinolones: a report of two cases. J Hepatol 1995;23:759-63.
10. Levinson JR, Kumar A. Ciprofloxacin-induced cholestatic jaundice: a case report. Am J Gastroenterol 1993;88:1619.
11. Gonzalez Carro P, Huidobro ML, Zabala AP, Vicente EM. Fatal subfulminant hepatic failure with ofloxacin (letter). Am J Gastroenterol 2000;95:1606.
12. Kahn JB. Latest industry information on the safety profile of levofloxacin in the US. Chemotherapy 2001;47(Suppl 3):32-7 discussion 44-8.
13. Yagawa K. Latest industry information on the safety profile of levofloxacin in Japan. Chemotherapy 2001;47(Suppl 3):38-3 discussion 44-8.
14. Carbon C. Levofloxacin adverse effects, data from clinical trials and pharmacovigilance. Therapie 2001;56(1):35-40.
15. Spahr L, Rubbia-Brandt L, Marinescu O, Armenian B, Hadengue A. Acute fired hepatitis related to levofloxacin. J Hepatol 2001;35:308-9.
16. Karim A, Ahmed S, Rossof LJ, Siddiqui RK, Steinberg HN. Possible Levofloxacin-induced acute hepatocellular injury in a patient with chronic obstructive lung disease. Clin Inf Dis 2001;33:2088-90.
17. Schwahn JD, Lee CH. Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient. CMAJ 2003 Apr 1;168:847-8.